本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Enliven Treateutics

22.45
-0.3300-1.45%
盘后22.450.00000.00%16:10 EDT
成交量:34.35万
成交额:776.83万
市值:12.90亿
市盈率:-11.62
高:23.21
开:22.53
低:21.99
收:22.78
数据加载中...
2024/07/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/29

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/07/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/20

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/06/18

重要事件披露

Form 8-K - Current report
2024/06/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/29

重要事件披露

Form 8-K/A - Current report: [Amend]
2024/05/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/20

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/05/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities